作者：
Thompson,R.A. [1]
;
Isin,E.M. [2]
;
Li,Y. [3]
;
Weidolf,L. [4]
;
Page,K. [5]
;
Wilson,I. [6]
;
Swallow,S. [7]
;
Middleton,B. ;
Stahl,S. ;
Foster,A.J. ;
Dolgos,H. ;
Weaver,R. ;
Kenna,J.G.
作者单位：
DMPK Innovative Medicine, AstraZeneca, M?lndal, 431 83, Sweden
[1]
Global Safety Assessment, AstraZeneca, Alderley Park, Macclesfield, Cheshire SK10 4TG, United
[2]
Discovery DMPK, AstraZeneca, Wilmington, DE, United States
[3]
DMPK Innovative Medicine, AstraZeneca, Alderley Park, Macclesfield, Cheshire SK10 4TG, United
[4]
Discovery DMPK, AstraZeneca, Loughborough, Leicestershire LE11 5RH, United Kingdom, XenoGesis Ltd.,
[5]
DMPK Innovative Medicine, AstraZeneca, M?lndal, 431 83, Sweden, Global DMPK, Merck-Serono S.A.,
[6]
Discovery Sciences, AstraZeneca, Alderley Park, Macclesfield, Cheshire SK10 4TG, United Kingdom
[7]
发布时间
2013-11-20
换一批
